SpectraCure AB (2OK) Stock Statistics & Valuation Metrics
Total Valuation
SpectraCure AB has a market cap or net worth of EUR 1.98M. The enterprise value is EUR 39.03M.
- Market Cap
- EUR 1.98M
- Enterprise Value
- EUR 39.03M
Share Statistics
SpectraCure AB has 1,426,541,500 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 1,426,541,500
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
SpectraCure AB’s return on equity (ROE) is -0.60 and return on invested capital (ROIC) is -56.40%.
- Return on Equity (ROE)
- -0.60
- Return on Assets (ROA)
- -0.54
- Return on Invested Capital (ROIC)
- -56.40%
- Return on Capital Employed (ROCE)
- -0.58
- Revenue Per Employee
- 0
- Profits Per Employee
- -4.31M
- Employee Count
- 13
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of SpectraCure AB is -0.13. SpectraCure AB’s PEG ratio is -0.00.
- PE Ratio
- -0.13
- PS Ratio
- 0.00
- PB Ratio
- 0.19
- Price to FCF
- -0.27
- Price to Operating Cash Flow
- -0.54
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, SpectraCure AB had revenue of 0 and earned -56.08M in profits. Earnings per share was -0.14.
- Revenue
- 0
- Gross Profit
- -30.14M
- Operating Income
- -54.35M
- Pretax Income
- -56.05M
- Net Income
- -56.08M
- EBITDA
- -51.81M
- Earnings Per Share (EPS)
- -0.14
Cash Flow
In the last 12 months, operating cash flow was -32.14M and capital expenditures -10.97M, giving a free cash flow of -32.28M billion.
- Operating Cash Flow
- -32.14M
- Free Cash Flow
- -32.28M
- Free Cash Flow per Share
- -0.03
Dividends & Yields
SpectraCure AB pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -368.69%
- Earnings Yield
- -318.24%
Stock Price Statistics
- Beta
- -85.34
- 52-Week Price Change
- -66.67%
- 50-Day Moving Average
- 0.01
- 200-Day Moving Average
- 0.01
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Important Dates
SpectraCure AB upcoming earnings date is Nov 13, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 21, 2026
- Next Earnings Date
- Nov 13, 2026
- Ex-Dividend Date
- ―
Financial Position
SpectraCure AB as a current ratio of 1.52, with Debt / Equity ratio of 3.21%
- Current Ratio
- 1.52
- Quick Ratio
- 1.52
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.20
- Interest Coverage Ratio
- -43.34
Taxes
In the past 12 months, SpectraCure AB has paid 27.00K in taxes.
- Income Tax
- 27.00K
- Effective Tax Rate
- -0.00
Enterprise Valuation
SpectraCure AB EV to EBITDA ratio is -0.41, with an EV/FCF ratio of -0.31.
- EV to Sales
- 0.00
- EV to EBITDA
- -0.41
- EV to Free Cash Flow
- -0.31
- EV to Operating Cash Flow
- -0.31
Balance Sheet
SpectraCure AB has EUR 7.63M in cash and marketable securities with EUR 8.91M in debt, giving a net cash position of -EUR 1.28M billion.
- Cash & Marketable Securities
- EUR 7.63M
- Total Debt
- EUR 8.91M
- Net Cash
- -EUR 1.28M
- Net Cash Per Share
- EUR 0.00
- Tangible Book Value Per Share
- EUR 0.00
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for SpectraCure AB is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- 15.38%
